{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T04:58:32Z","timestamp":1778734712883,"version":"3.51.4"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"18","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2018,5,22]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p> Diabetes mellitus type 2 (DMT2) is an endocrine disease of global\nproportions which is currently affecting 1 in 12 adults in the world, with still increasing\nprevalence. World Health Organization (WHO) declared this worldwide health problem, as an\nepidemic disease, to be the only non-infectious disease with such categorization. People with\nDMT2 are at increased risk of various complications and have shorter life expectancy. The\nmain classes of oral antidiabetic drugs accessible today for DMT2 vary in their chemical\ncomposition, modes of action, safety profiles and tolerability.\n<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p> A systematic search of peer-reviewed scientific literature and public databases has\nbeen conducted. We included the most recent relevant research papers and data in respect to\nthe focus of the present review. The quality of retrieved papers was assessed using standard\ntools.\n<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p> The review highlights the chemical structural diversity of the molecules that have the\ncommon target-DMT2. So-called traditional antidiabetics as well as the newest and the least\nexplored drugs include polypeptides and amino acid derivatives (insulin, glucagon-like peptide\n1, dipeptidyl peptidase-IV inhibitors, amylin), sulfonylurea derivatives, benzylthiazolidine-\n2,4-diones (peroxisome proliferator activated receptor-\u03b3 agonists\/glitazones),\ncondensed guanido core (metformin) and sugar-like molecules (\u03b1-glucosidase and sodium\/\nglucose co-transporter 2 inhibitors).\n<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>As diabetes becomes a more common disease, interest in new pharmacological\ntargets is on the rise.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0929867325666171205145309","type":"journal-article","created":{"date-parts":[[2017,12,6]],"date-time":"2017-12-06T14:34:48Z","timestamp":1512570888000},"page":"2140-2165","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Antidiabetics: Structural Diversity of Molecules with a Common Aim"],"prefix":"10.2174","volume":"25","author":[{"given":"Jelena B.","family":"Popovic-Djordjevic","sequence":"first","affiliation":[{"name":"Department of Chemistry and Biochemistry, Faculty of Agriculture, University of Belgrade, Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivana I.","family":"Jevtic","sequence":"additional","affiliation":[{"name":"Center of Chemistry, Institute of Chemistry, Technology and Metallurgy, University of Belgrade, Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatjana P.","family":"Stanojkovic","sequence":"additional","affiliation":[{"name":"Institute of Oncology and Radiology of Serbia, Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/158102","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/158102\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/158102","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,25]],"date-time":"2020-12-25T09:58:29Z","timestamp":1608890309000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/158102\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,22]]},"references-count":0,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2018,5,22]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867325666171205145309","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5,22]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2017-06-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-11-08","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-11-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-05-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}